Autism Spectrum Disorder clinical trials

Explore recruiting autism spectrum disorder clinical trials.

Recruiting autism spectrum disorder studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Autism Spectrum Disorder trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An open label safety and efficacy study of allogenic adipose tissue-derived mesenchymal stromal cells on autism and gastrointestinal symptoms

Denmark

Human Pharmacology (Phase I)- Other EU CTIS Study details

Long-term neuropsychologic outcome of pre-emptive mTOR inhibitor treatment in children with tuberous sclerosis complex (TSC) under 4 months of age (PROTECT)

Germany, Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomized, placebo-controlled, double-blind, 2-period cross-over study in youth with autism spectrum disorders evaluating social and repetitive behaviors after four weeks of twice daily-doses of 24IU of intranasally administered oxytocin

Norway

Therapeutic exploratory (Phase II) EU CTIS Study details

Effect of faecal microbiota transplant on the expression of autism spectrum disorder core symptoms in children – open-label phase II clinical trial (FMT-PAS)

Czechia

Therapeutic exploratory (Phase II) EU CTIS Study details

Safety and pharmacokinetics of antipsychotics in children 2: Studying TDM in an RCT

Netherlands, Germany

Therapeutic use (Phase IV) EU CTIS Study details

ALaDIN - Use of low doses of interleukin-2 in autism spectrum disorders

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Autism Spectrum Disorder trials by city

Autism Spectrum Disorder in Toronto Autism Spectrum Disorder in Vancouver Autism Spectrum Disorder in Montreal Autism Spectrum Disorder in Calgary Autism Spectrum Disorder in Edmonton Autism Spectrum Disorder in Ottawa Autism Spectrum Disorder in Winnipeg Autism Spectrum Disorder in Quebec City Autism Spectrum Disorder in Hamilton Autism Spectrum Disorder in Kitchener Autism Spectrum Disorder in London Autism Spectrum Disorder in Halifax Autism Spectrum Disorder in New York Autism Spectrum Disorder in Los Angeles Autism Spectrum Disorder in Chicago Autism Spectrum Disorder in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease